688197.SHG Shouyao Holdings (Beijing) Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
34.90 CNY
Close of Nov 4, 2026
29.71 46.25
Market cap
CNY 5.19B
P/E
-
P/B
7.55x
ROE
-9.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688197.SHG undervalued?

Graham number

The Graham number of Shouyao Holdings (Beijing) Co. Ltd. A cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shouyao Holdings (Beijing) Co. Ltd. A fundamental analysis

No fundamental analysis for Shouyao Holdings (Beijing) Co. Ltd. A yet.

Shouyao Holdings (Beijing) Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shouyao Holdings (Beijing) Co. Ltd. A

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.

Full company profile